Market Research Logo

Tomophase Corp - Product Pipeline Analysis, 2017 Update

Summary

Tomophase Corp (Tomophase) is a medical device company that offers light-based imaging and therapy solutions. The company develops and commercializes opto-medical devices. It offers endoscopic tissue imaging system based on its proprietary technology optical coherence tomography. Tomophase's products are used in pulmonary stent development, early stage lung cancer, pulmonary fibrosis, asthma research, aerosol drug development and surgical guidance. The company develops pulmonary medicine technologies for the tomographic imaging of airways and pulmonary tissue. It markets its products across the US. Tomophase is headquartered in Cambridge, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Tomophase Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Tomophase Corp Company Overview
Tomophase Corp Company Snapshot
Tomophase Corp Pipeline Products and Ongoing Clinical Trials Overview
Tomophase Corp – Pipeline Analysis Overview
Tomophase Corp - Key Facts
Tomophase Corp - Major Products and Services
Tomophase Corp Pipeline Products by Development Stage
Tomophase Corp Pipeline Products Overview
Tomophase OCTIS Imaging system - Asthma
Tomophase OCTIS Imaging system - Asthma Product Overview
Tomophase OCTIS Imaging system - Lung Cancer
Tomophase OCTIS Imaging system - Lung Cancer Product Overview
Tomophase OCTIS Imaging system - Pulmonary Fibrosis
Tomophase OCTIS Imaging system - Pulmonary Fibrosis Product Overview
Tomophase Corp - Key Competitors
Tomophase Corp - Key Employees
Tomophase Corp - Locations And Subsidiaries
Head Office
Recent Developments
Tomophase Corp, Recent Developments
May 20, 2013: Tomophase Announces First Human Clinical Images Available With OCT Imaging System
Jul 05, 2011: Tomophase Receives Ninth US Patent For Integrated Disease Diagnosis And Treatment System
Apr 11, 2011: Tomophase Announces First Sale Of OCT Imaging System For Research Use To University Of Texas
Dec 10, 2010: Tomophase Receives FDA 510(k) Clearance To Market OCTIS
Nov 15, 2010: Tomophase Receives Eighth Patent: Mapping Physiological Functions Of Tissues In Lungs And Other Organs
Apr 27, 2010: Tomophase’s Fiber-Optic Imaging Catheter Receives Seventh US Patent
Mar 22, 2010: Tomophase Appoints Ralph S. Johnston As President, COO
Oct 16, 2008: Tomophase To Exhibit First Cross-Sectional Images Of Human Bronchus Using Proprietary OCT System
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Tomophase Corp Pipeline Products and Ongoing Clinical Trials Overview
Tomophase Corp Pipeline Products by Equipment Type
Tomophase Corp Pipeline Products by Indication
Tomophase Corp, Key Facts
Tomophase Corp, Major Products and Services
Tomophase Corp Number of Pipeline Products by Development Stage
Tomophase Corp Pipeline Products Summary by Development Stage
Tomophase OCTIS Imaging system - Asthma - Product Status
Tomophase OCTIS Imaging system - Asthma - Product Description
Tomophase OCTIS Imaging system - Lung Cancer - Product Status
Tomophase OCTIS Imaging system - Lung Cancer - Product Description
Tomophase OCTIS Imaging system - Pulmonary Fibrosis - Product Status
Tomophase OCTIS Imaging system - Pulmonary Fibrosis - Product Description
Tomophase Corp, Key Employees
Glossary
List of Figures
Tomophase Corp Pipeline Products by Equipment Type
Tomophase Corp Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report